Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: AbbVie Inc., 3 years.
AbbVie Inc.
Director
Xos Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AbbVie Inc. May 8, 202594.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Xos Inc. | Grant or award | +2,670 | — | — |
| Jul 10, 2026 | Xos Inc. | Grant or award | +60,584 | — | — |
| May 8, 2026 | AbbVie Inc. | Grant or award | +1,118 | — | — |
| Apr 10, 2026 | Xos Inc. | Grant or award | +5,182 | — | — |
| Jan 10, 2026 | Xos Inc. | Grant or award | +2,401 | — | — |
| Oct 10, 2025 | Xos Inc. | Grant or award | +1,883 | — | — |
| Jul 10, 2025 | Xos Inc. | Grant or award | +62,377 | — | — |
| Jul 10, 2025 | Xos Inc. | Grant or award | +1,601 | — | — |
| May 9, 2025 | AbbVie Inc. | Grant or award | +1,203 | — | — |
| Apr 10, 2025 | Xos Inc. | Grant or award | +1,407 | — | — |
| Jan 10, 2025 | Xos Inc. | Grant or award | +1,065 | — | — |
| Oct 10, 2024 | Xos Inc. | Grant or award | +1,065 | — | — |
| Jul 10, 2024 | Xos Inc. | Grant or award | +28,694 | — | — |
| Jul 10, 2024 | Xos Inc. | Grant or award | +717 | — | — |
| May 3, 2024 | AbbVie Inc. | Grant or award | +1,322 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.